(SNCA) |
| 0 (0%) 09-03 03:45 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | |
| 52w Low: |
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Mon, 13 Jul 2026
α-Synuclein burden amplification in Parkinson’s disease: a unified genetic, molecular, and cellular framework - Frontiers
Mon, 27 Apr 2026
Noncoding variation and regulatory control of SNCA in Lewy body dementia - npj Dementia - Nature
Tue, 31 Mar 2026
Autophagy Defects in SNCA Triplication Neurons - bioengineer.org
Thu, 19 Feb 2026
Mitochondria and aging: A central axis in Parkinson’s disease pathogenesis - EurekAlert!
Wed, 04 Feb 2026
Artificial miRNA-mediated reduction of SNCA for the treatment of α-synucleinopathies - ScienceDirect.com
Wed, 28 Jan 2026
α-Synuclein expression is required for somatodendritic dopamine release and immediate early gene induction - Science | AAAS
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
